Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples